Carcinoma, Merkel Cell - 24 Studies Found
| Recruiting |
: Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200) : Carcinoma, Merkel Cell : 2014-06-02 : Drug: Avelumab Avelumab will be administered at a dose of 10 milligram per kilogram (mg/kg) as 1-hour in |
| Recruiting |
: MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2015-07-28 : Drug: MLN0128 Investigational mTOR kinase inhibitor |
| Recruiting |
: F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2014-01-31 :
|
| Active, not recruiting |
: A Proof-of-Concept Trial of GLA-SE in Patients With Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2014-01-10 : Biological: GLA-SE Glucopyranosyl Lipid A in Stable Emulsion |
| Recruiting |
: Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With 3 mg/kg BW Ipilimumab (Yervoy®) Versus Observation : Merkel Cell Carcinoma : 2014-06-20 : Drug: Ipilimumab adjuvant treatment of completely resected Merkel cell carcinoma |
| Recruiting |
: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues : Carcinoma, Merkel Cell : 2015-01-13 : Drug: Lanreotide Other Name: Somatuline |
| Available |
: Expanded Access to Avelumab for Treatment of Metastatic Merkel Cell Carcinoma (mMCC) : Metastatic Merkel Cell Carcinoma : 2017-03-20 : Drug: Avelumab Avelumab should be administered intravenously as per the recommended dose. Administration |
| Withdrawn |
: Study of the Drug Ipilimumab for Metastatic Merkel Cell Carcinoma : Merkel Cell Carcinoma : 2013-07-28 : Drug: Ipilimumab Ipilimumab is a recombinant, human monoclonal antibody that binds to CTLA-4. It is comm |
| Completed |
: IL-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Patients With Merkel Cell Cancer : Merkel Cell Carcinoma : 2011-09-23 :
|
| Terminated |
: Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma :
|